Literature DB >> 10761697

Nuclear localisation of wild type and mutant galectin-3 in transfected cells.

J C Gaudin1, B Mehul, R C Hughes.   

Abstract

Galectin-3, a member of a family of carbohydrate-binding proteins, is present generally in the cytoplasm of cells. However, galectin 3 can also be located in nuclei under certain conditions although it lacks any known nuclear localisation signal and the mechanism by which the protein is sequestered in nuclei is unknown. Here we describe that Cos-7 cells or rabbit smooth muscle Rb-1 cells transfected with cDNA encoding hamster galectin-3 sequester the protein in nuclei whereas untransfected BHK cells expressing the endogenous hamster lectin or transfected BHK cells over-expressing the protein, do not. Confocal immunofluorescence microscopy of Cos-7 cells or rabbit smooth muscle Rb-1 cells transfected with cDNAs encoding mutants of hamster galectin-3 containing N-terminal or internal deletions shows that nuclear localisation does not require the first 103 amino acid residues of the protein. Further deletion of residues 104-110 dramatically prevents sequestration in nuclei. However, the sequence A104PTGALT110 by itself is not obligatory for nuclear localisation and can be substituted by other unrelated sequences. A truncated galectin-3 protein, that is blocked in nuclear expression, retains carbohydrate-binding activity, making less likely the possibility that severe N-terminal truncations of galectin-3 induce mis-folding leading to aggregation and cytoplasmic sequestration and an incidental effect on nuclear trafficking. These studies indicate that nuclear import and retention of galectin-3 is a property of the CRD domain and is independent of N-terminal domains that others have shown to contain binding domains for various nuclear components.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761697     DOI: 10.1016/S0248-4900(00)88763-8

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  10 in total

Review 1.  Advanced glycation end products, diabetes and ageing.

Authors:  N Nass; B Bartling; A Navarrete Santos; R J Scheubel; J Börgermann; R E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

Review 2.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

Review 3.  Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose.

Authors:  D T Klink; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 4.  Dynamics of galectin-3 in the nucleus and cytoplasm.

Authors:  Kevin C Haudek; Kimberly J Spronk; Patricia G Voss; Ronald J Patterson; John L Wang; Eric J Arnoys
Journal:  Biochim Biophys Acta       Date:  2009-07-16

5.  Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains.

Authors:  F Zong; E Fthenou; J Castro; B Péterfia; I Kovalszky; L Szilák; G Tzanakakis; K Dobra
Journal:  Cell Prolif       Date:  2009-10-13       Impact factor: 6.831

Review 6.  Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway.

Authors:  Susumu Nakahara; Avraham Raz
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 7.  Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus.

Authors:  Ronald J Patterson; Weizhong Wang; John L Wang
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

8.  Effect of galectin-3 on the behavior of Eca‑109 human esophageal cancer cells.

Authors:  Ning Liang; Xiaoming Song; Jian Xie; Deguo Xu; Fengjun Liu; Xinshuang Yu; Yuan Tian; Zhen Liu; Lili Qiao; Jiandong Zhang
Journal:  Mol Med Rep       Date:  2014-11-05       Impact factor: 2.952

Review 9.  Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments.

Authors:  Ana Carolina Ferreira Cardoso; Luciana Nogueira de Sousa Andrade; Silvina Odete Bustos; Roger Chammas
Journal:  Front Oncol       Date:  2016-05-23       Impact factor: 6.244

10.  Galectin-3 interacts with components of the nuclear ribonucleoprotein complex.

Authors:  Katharina Fritsch; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Alexander Brehm; Ralf Jacob
Journal:  BMC Cancer       Date:  2016-07-19       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.